Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1Breast 1

Conditions

Neoplasms 1Head and Neck Neoplasms 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Virtual Reality Exposure Therapy × Clear all
NCT05135260 2024-10-16

Virtual Reality on Pain, Stress, and Affect in the Infusion Clinic

Vanderbilt-Ingram Cancer Center

Phase NA Completed
99 enrolled
Tumor-Agnostic

Neoplasms

NCT04419077 2023-09-05

REV

Hospices Civils de Lyon

Phase NA Completed
41 enrolled
BreastHead & Neck

Anxiety Disorders, Breast Neoplasms, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡